# Sunmed Capital

> Sunmed Capital is a VC fund in Sanya backing Medical Device, Health Care and Manufacturing. See 3 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Sanya, China
- Total investments: 3
- Last investment: Feb 2025
- Lead investor: 0%
- Last updated: Aug 2026
- Website: http://www.sunmedcapital.com

Sunmed Capital is a VC fund in Sanya focused on Medical Device and Health Care. Sunmed Capital is dedicated to promote innovation in medical devices by working closely with physicians, engineers, and other entrepreneurs.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical Device | 3 | 100% |
| Health Care | 2 | 67% |
| Manufacturing | 1 | 33% |
| Health Diagnostics | 1 | 33% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 1 | 33% |
| Series B | 1 | 33% |
| Series C | 1 | 33% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 2 | 67% |
| China | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| TECLens | TECLens is creating a crosslinking technology that may accurately fix vision issues in healthy eyes as well as treat keratoconus. It provides patients with presbyopia with the ability to regain their ability to read at a distance, controls children's progressive myopia, corrects adult vision problems like hyperopia and low-order myopia, andmore. | $9.3M | Series A | Feb 11, 2025 |  |
| ZD Medical | ZD Medical develops phase variance optical coherence tomography that can detect macular degeneration and retinal microvascular proliferation caused by diabetes at the same time. It is a non-invasive, early-detection technology for diabetic retinopathy. ZD Medical's phase variance optical coherence tomography can detect both maculardegeneration and retinal microvascular proliferation caused by diabetes. ZD Medical brings together scientific and technological elites from both at home and abroad to pursue the development and manufacture of high-quality medical devices, and is dedicated to providing practical overall solutions for medical diagnosis and clinical treatment in order to benefit humanity's medical and health causes. | $14M | Series C | Nov 01, 2024 |  |
| Noah Medical | Noah Medical is a manufacturer of medical robotic devices used to diagnose and treat patients in a variety of settings. The company's devices perform early diagnoses and treatments in advanced clinical settings, allowing hospitals to treat patients earlier and save lives while leaving only minor scars. | $150M | Series B | Apr 19, 2023 |  |

3 of 3 investments shown.

## Co-investors
- [1955 Capital](https://shizune.co/investors/profile/1955-capital) — VC Fund, 1 deal together
- [AME Cloud Ventures](https://shizune.co/investors/profile/ame-cloud-ventures) — VC Fund, 1 deal together
- [Hankang Capital](https://shizune.co/investors/profile/hankang-capital) — VC Fund, 1 deal together
- [Hillhouse Capital](https://shizune.co/investors/profile/hillhouse-capital-ff0c) — VC Fund, 1 deal together
- [HSG](https://shizune.co/investors/profile/hsg-cap) — VC Fund, 1 deal together
- [Hyfinity Investments](https://shizune.co/investors/profile/hyfinity-investments) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Sunmed Capital invest in?

Sunmed Capital invests primarily in Medical Device, Health Care and Manufacturing startups, most often at Series A and Series B stage. Most of the 3 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Sunmed Capital last invest?

The most recent investment recorded for Sunmed Capital closed in Feb 2025. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co